Aconitase regulation of erythropoiesis correlates with a novel licensing function in erythropoietin-induced ERK signaling

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Talbot, Anne Laure ^a   Bullock, Grant C ^a   Delehanty, Lorrie L ^a   Sattler, Martin ^b   Zhao, Zhizhuang Joe ^c   Goldfarb, Adam N ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACONITASE INHIBITOR; ACONITATE HYDRATASE; ENZYME INHIBITOR; ERYTHROPOIETIN; FLUOROACETATE SODIUM; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APLASTIC ANEMIA; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE COUNT; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOUSE; NONHUMAN; PHLEBOTOMY; POLYCYTHEMIA VERA; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY;

MURINAE; MUS;

ACONITATE HYDRATASE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME INHIBITORS; ERYTHROPOIESIS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; POLYCYTHEMIA VERA;

EID: 80051916158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023850     Document Type: Article

References (67)

1. Finch CA, (1982) Erythropoiesis, erythropoietin, and iron. Blood 60: 1241-1246.
2. Kimura H, Finch CA, Adamson JW, (1986) Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia. J Cell Physiol 126: 298-306.
3. Goodnough LT, Skikne B, Brugnara C, (2000) Erythropoietin, iron, and erythropoiesis. Blood 96: 823-833.
4. Bullock GC, Delehanty LL, Talbot A-L, Gonias SL, Tong W-H, et al. (2010) Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood 116: 97-108.
5. Tong WH, Rouault TA, (2007) Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals 20: 549-564.
6. Nulton-Persson AC, Szweda LI, (2001) Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 276: 23357-23361.
7. Zhang S-J, Sandstrom ME, Lanner JT, Thorell A, Westerblad H, et al. (2007) Activation of aconitase in mouse fast-twitch skeletal muscle during contraction-mediated oxidative stress. Am J Physiol Cell Physiol 293: C1154-1159.
8. Deck KM, Vasanthakumar A, Anderson SA, Goforth JB, Kennedy MC, et al. (2009) Evidence That Phosphorylation of Iron Regulatory Protein 1 at Serine 138 Destabilizes the [4Fe-4S] Cluster in Cytosolic Aconitase by Enhancing 4Fe-3Fe Cycling. Journal of Biological Chemistry 284: 12701-12709.
9. Lin G, Brownsey R, MacLeod K, (2009) Regulation of mitochondrial aconitase by phosphorylation in diabetic rat heart. Cellular and Molecular Life Sciences 66: 919-932.
10. Haile DJ, Rouault TA, Tang CK, Chin J, Harford JB, et al. (1992) Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A 89: 7536-7540.
11. Chen XJ, Wang X, Butow RA, (2007) Yeast aconitase binds and provides metabolically coupled protection to mitochondrial DNA. Proceedings of the National Academy of Sciences 104: 13738-13743.
12. Arcasoy MO, Jiang X, (2005) Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor. British Journal of Haematology 130: 121-129.
13. Halupa A, Chohan M, Stickle NH, Beattie BK, Miller BA, et al. (2005) Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase C[gamma]. Experimental Cell Research 309: 1-11.
14. Klingmüller U, (1997) The Role of Tyrosine Phosphorylation in Proliferation and Maturation of Erythroid Progenitor Cells. European Journal of Biochemistry 249: 637-647.
15. Shaul YD, Seger R, (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773: 1213-1226.
16. Casar B, Arozarena I, Sanz-Moreno V, Pinto A, Agudo-Ibanez L, et al. (2009) Ras Subcellular Localization Defines Extracellular Signal-Regulated Kinase 1 and 2 Substrate Specificity through Distinct Utilization of Scaffold Proteins. Mol Cell Biol 29: 1338-1353.
17. Teis D, Wunderlich W, Huber LA, (2002) Localization of the MP1-MAPK Scaffold Complex to Endosomes Is Mediated by p14 and Required for Signal Transduction. Developmental Cell 3: 803-814.
18. Torii S, Kusakabe M, Yamamoto T, Maekawa M, Nishida E, (2004) Sef Is a Spatial Regulator for Ras/MAP Kinase Signaling. Developmental Cell 7: 33-44.
19. Jaaro H, Rubinfeld H, Hanoch T, Seger R, (1997) Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proceedings of the National Academy of Sciences of the United States of America 94: 3742-3747.
20. Galli S, Jahn O, Hitt R, Hesse D, Opitz L, et al. (2009) A New Paradigm for MAPK: Structural Interactions of hERK1 with Mitochondria in HeLa Cells. PLoS ONE 4: e7541.
21. Zhang J, Lodish HF, (2004) Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors. Blood 104: 1679-1687.
22. Guihard S, Clay D, Cocault L, Saulnier N, Opolon P, et al. (2010) The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis. Blood 115: 3686-3694.
23. Abutin RM, Chen J, Lung TK, Lloyd JA, Sawyer ST, et al. (2009) Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells. Experimental Hematology 37: 151-158.
24. Spivak JL, (2002) Polycythemia vera: myths, mechanisms, and management. Blood 100: 4272-4290.
25. Vannucchi AM, Guglielmelli P, Tefferi A, (2009) Advances in Understanding and Management of Myeloproliferative Neoplasms. CA: A Cancer Journal for Clinicians 59: 171-191.
26. Elliott MA, Tefferi A, (2005) Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. British Journal of Haematology 128: 275-290.
27. Lauble H, Kennedy MC, Emptage MH, Beinert H, Stout CD, (1996) The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex. Proceedings of the National Academy of Sciences of the United States of America 93: 13699-13703.
28. Isken F, Schulz TJ, Möhlig M, Pfeiffer AFH, Ristow M, (2006) Chemical Inhibition of Citrate Metabolism Alters Glucose Metabolism in Mice. Hormone and Metabolic Research pp. 543-545.
29. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, et al. (2001) Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98: 3261-3273.
30. Chen K, Liu J, Heck S, Chasis JA, An X, et al. (2009) Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proceedings of the National Academy of Sciences 106: 17413-17418.
31. Menon MP, Karur V, Bogacheva O, Bogachev O, Cuetara B, et al. (2006) Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J Clin Invest 116: 683-694.
32. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, et al. (2004) Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23: 386-395.
33. Spivak JL, (2005) The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer 5: 543-555.
34. Pop R, Shearstone JR, Shen Q, Liu Y, Hallstrom K, et al. (2010) A Key Commitment Step in Erythropoiesis Is Synchronized with the Cell Cycle Clock through Mutual Inhibition between PU.1 and S-Phase Progression. PLoS Biol 8: e1000484.
35. Hardie DG, Hawley SA, Scott JW, (2006) AMP-activated protein kinase-development of the energy sensor concept. J Physiol 574: 7-15.
36. Setsukinai K-i, Urano Y, Kakinuma K, Majima HJ, Nagano T, (2003) Development of Novel Fluorescence Probes That Can Reliably Detect Reactive Oxygen Species and Distinguish Specific Species. Journal of Biological Chemistry 278: 3170-3175.
37. Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, et al. (1996) Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 44: 1363-1372.
38. Haq R, Halupa A, Beattie BK, Mason JM, Zanke BW, et al. (2002) Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases. J Biol Chem 277: 17359-17366.
39. Magocsi M, Apati A, Gati R, Kolonics A, (1999) Signalling mechanisms and the role of calcineurin in erythropoiesis. Immunol Lett 68: 187-195.
40. Einar Andreas S, Marit Elise H, Kristine Bjerve G, Guri D, Erlend Bremertun S, et al. (2006) PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells. British Journal of Haematology 135: 117-128.
41. Schmidt E, Fichelson S, Feller S, (2004) PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. BMC Biology 2: 7.
42. Liao HJ, Kume T, McKay C, Xu MJ, Ihle JN, et al. (2002) Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. Journal of Biological Chemistry 277: 9335-9341.
43. Anjum R, Blenis J, (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9: 747-758.
44. Stark C, Breitkreutz B-J, Reguly T, Boucher L, Breitkreutz A, et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Research 34: D535-D539.
45. Obenauer JC, Cantley LC, Yaffe MB, (2003) Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucl Acids Res 31: 3635-3641.
46. Philipova R, Whitaker M, (2005) Active ERK1 is dimerized in vivo: bisphosphodimers generate peak kinase activity and monophosphodimers maintain basal ERK1 activity. J Cell Sci 118: 5767-5776.
47. Casar B, Pinto A, Crespo P, (2008) Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell 31: 708-721.
48. Xing S, Wanting TH, Zhao W, Ma J, Wang S, et al. (2008) Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood 111: 5109-5117.
49. Quintas-Cardama A, Vaddi K, Liu P, Manshouri T, Li J, et al. (2010) Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood 115: 3109-3117.
50. Zou H, Yan D, Mohi G, (2011) Differential biological activity of disease-associated JAK2 mutants. FEBS Letters 585: 1007-1013.
51. Greer JP, (2008) Wintrobe's Clinical Hematology Hagerstown Lippincott, Williams & Wilkins.
52. Lyoumi S, Abitbol M, Andrieu V, Henin D, Robert E, et al. (2007) Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice. Blood 109: 811-818.
53. Savarie PJ, (1984) Toxic characteristics of fluorocitrate, the toxic metabolite of compound 1080. In: D.O. C, editors. Proceedings Eleventh Vertebrate Pest Conference Lincoln pp. 132-137.
54. Sankaran VG, Orkin SH, Walkley CR, (2008) Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes and Development 22: 463-475.
55. Leiter LM, Thatte HS, Okafor C, Marks PW, Golan DE, et al. (1999) Chloramphenicol-induced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions. J Cell Physiol 180: 334-344.
56. Inoue S-I, Yokota M, Nakada K, Miyoshi H, Hayashi J-I, (2007) Pathogenic mitochondrial DNA-induced respiration defects in hematopoietic cells result in anemia by suppressing erythroid differentiation. FEBS Letters 581: 1910-1916.
57. Diwan A, Koesters AG, Odley AM, Pushkaran S, Baines CP, et al. (2007) Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proceedings of the National Academy of Sciences 104: 6794-6799.
58. Chen ML, Logan TD, Hochberg ML, Shelat SG, Yu X, et al. (2009) Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 114: 4045-4053.
59. Alonso M, Melani M, Converso D, Jaitovich A, Paz C, et al. (2004) Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development. Journal of Neurochemistry 89: 248-256.
60. Poderoso C, Converso DP, Maloberti P, Duarte A, Neuman I, et al. (2008) A Mitochondrial Kinase Complex Is Essential to Mediate an ERK1/2-Dependent Phosphorylation of a Key Regulatory Protein in Steroid Biosynthesis. PLoS ONE 3: e1443.
61. Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, et al. (2000) Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 95: 2983-2989.
62. Goncharov NV, Jenkins RO, Radilov AS, (2006) Toxicology of fluoroacetate: a review, with possible directions for therapy research. Journal of Applied Toxicology 26: 148-161.
63. Wernig G, Gonneville JR, Crowley BJ, Rodrigues MS, Reddy MM, et al. (2008) The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes. Blood 111: 3751-3759.
64. Elagib KE, Xiao M, Hussaini IM, Delehanty LL, Palmer LA, et al. (2004) Jun Blockade of Erythropoiesis: Role for Repression of GATA-1 by HERP2. Molecular and Cellular Biology 24: 7779-7794.
65. Choi Y, Elagib KE, Delehanty LL, Goldfarb AN, (2006) Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1. Cancer Res 66: 2990-2996.
66. Seger R, Pinto A, Crespo P, (2010) Analysis of ERKs' Dimerization by Electrophoresis MAP Kinase Signaling Protocols: Humana Press pp. 335-342.
67. Nobes PR, Carter AB, (1990) Reticulocyte counting using flow cytometry. J Clin Pathol 43: 675-678.